A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

The folks over at Android Authority managed to activate this under-development Gemini feature in Meet version 277.0.693808058 ...

Google is rolling out its Gemini AI to more products, including Google Meet on Android. Now, users can generate custom ...

Wall Street hits new highs, closing its best week in a year as the S&P 500 briefly crosses 6,000. Major boosts came from Axon ...

Google is generally rolling out its Gemini AI-powered Vids app that lets you create video presentations using a prompt. Some ...

The future of work is undergoing a seismic transformation. From remote and hybrid work models to automation and advanced workforce technology, leaders must act now.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

In the first study, titled "The Anti-tumor Response of BPM31510 is Associated with Immune Cell Regulation in the Tumor Microenvironment," researchers showed that BPM31510 significantly increases ...

Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic cell states of cancer, today announced that the Company ...